Open AccessRenin-angiotensin system blockers-SGLT2 inhibitors-mineralocorticoid receptor antagonists in diabetic kidney disease: A tale of the past two decades!
Author(s) -
Awadhesh Kumar Singh,
Ritu Singh
Publication year - 2022
Publication title -
world journal of diabetes
Language(s) - English
Resource type - Journals
ISSN - 1948-9358
DOI - 10.4239/wjd.v13.i7.471
Subject(s) - empagliflozin , medicine , mineralocorticoid receptor , canagliflozin , dapagliflozin , albuminuria , kidney disease , spironolactone , type 2 diabetes mellitus , urology , diabetes mellitus , aliskiren , eplerenone , endocrinology , type 2 diabetes , aldosterone , diabetic nephropathy , renin–angiotensin system , blood pressure
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom